DocDollars

Tolmar, Inc.

CO · United States · Reporting entity ID 100000010803

Total reported 2019–2025
$7.92M
#567 of 2,960 reporting companies — 0% of all reported industry payments
$1.30M in general payments across 34,551 records, plus $6.63M in research funding across 3,321 records.

How it breaks down

General payments $1,298,781
Research funding $6,625,172

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Tolmar, Inc. reported $7.92M to US doctors and teaching hospitals from 2019 to 2025, ranking #567 of 2,960 reporting companies. 84% of that was research funding and 16% general payments such as consulting, speaking, food and travel. 34,551 general payment records and 3,321 research records were filed.

Common questions about Tolmar, Inc.

How much has Tolmar, Inc. paid US doctors?

Tolmar, Inc. reported $7,923,953 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,298,781 in general payments, $6,625,172 in research funding.

How does Tolmar, Inc. rank among drug and device companies?

It ranks #567 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Tolmar, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.